FDA Orange Book · active-ingredient family
Methotrexate sodium
Methotrexate sodium is approved as 3 brand and 52 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:XATMEP · NDA 208400
3
Brand (NDA)
52
Generics (ANDA)
7
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, solution, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| XATMEPRLD | AZURITY | NDA 208400 | — | Apr 25, 2017 | |
| METHOTREXATE LPFRLD×12 | HOSPIRA | NDA 011719 | — | Mar 31, 1982 | |
| METHOTREXATE SODIUMRLD | STRIDES PHARMA INTL | NDA 008085 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (52)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| METHOTREXATE SODIUM | HETERO LABS LTD VI | ANDA 219865 | AP | Apr 30, 2026 | |
| METHOTREXATE SODIUM×2 | ALEMBIC | ANDA 220225 | AP | Apr 15, 2026 | |
| METHOTREXATE SODIUM | ALEMBIC | ANDA 217552 | AB | Jun 03, 2024 | |
| METHOTREXATE SODIUM | ELITE LABS INC | ANDA 216453 | AB | May 16, 2024 | |
| METHOTREXATE SODIUM | DAITO | ANDA 213362 | — | Aug 07, 2023 | |
| METHOTREXATE SODIUM | LOTUS PHARM CO LTD | ANDA 209787 | — | Apr 23, 2021 | |
| METHOTREXATE SODIUM | EUGIA PHARMA | ANDA 210454 | AB | Jan 30, 2020 | |
| METHOTREXATE SODIUM | ACCORD HLTHCARE | ANDA 213343 | AB | Jan 24, 2020 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE×3 | SAGENT PHARMS INC | ANDA 203407 | AP | Aug 09, 2018 | |
| METHOTREXATE SODIUM | AMNEAL PHARMS | ANDA 210040 | — | Dec 22, 2017 | |
| METHOTREXATE SODIUM | ZYDUS PHARMS | ANDA 207812 | AB | Jan 13, 2017 | |
| METHOTREXATE SODIUM | SUN PHARM | ANDA 201749 | AB | May 21, 2015 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE×4 | EUGIA PHARMA SPECLTS | ANDA 201529 | AP | Mar 29, 2012 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | EXTROVIS | ANDA 201530 | — | Mar 29, 2012 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE×4 | PHARMACHEMIE BV | ANDA 040843 | AP | Jan 11, 2010 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | CAPLIN ONE LABS | ANDA 090029 | — | Mar 31, 2009 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE×2 | CAPLIN ONE LABS | ANDA 090039 | — | Mar 31, 2009 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | ACCORD HLTHCARE | ANDA 040716 | AP | Apr 30, 2007 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | ACCORD HLTHCARE | ANDA 040767 | AP | Apr 30, 2007 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | ACCORD HLTHCARE | ANDA 040768 | AP | Apr 30, 2007 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | HIKMA | ANDA 040632 | AP | Aug 12, 2005 | |
| TREXALL×4 | BARR | ANDA 040385 | — | Mar 21, 2001 | |
| METHOTREXATE SODIUM | DURAMED PHARMS BARR | ANDA 040233 | — | Jun 17, 1999 | |
| METHOTREXATE PRESERVATIVE FREE | FRESENIUS KABI USA | ANDA 040266 | AP | Feb 26, 1999 | |
| METHOTREXATE PRESERVATIVE FREE | FRESENIUS KABI USA | ANDA 040265 | — | Feb 26, 1999 | |
| METHOTREXATE SODIUM×2 | FRESENIUS KABI USA | ANDA 040263 | AP | Feb 26, 1999 | |
| METHOTREXATE SODIUM | HIKMA | ANDA 040054 | AB | Aug 01, 1994 | |
| METHOTREXATE SODIUM | MYLAN | ANDA 081235 | AB | May 15, 1992 | |
| FOLEX PFS | PHARMACIA AND UPJOHN | ANDA 081242 | — | Aug 23, 1991 | |
| METHOTREXATE SODIUM | BARR | ANDA 081099 | AB | Oct 15, 1990 | |
| MEXATE-AQ PRESERVED | BRISTOL MYERS SQUIBB | ANDA 089887 | — | Apr 14, 1989 | |
| METHOTREXATE SODIUM | PHARMACHEMIE USA | ANDA 089158 | — | Jul 08, 1988 | |
| ABITREXATE | ABIC | ANDA 089354 | — | Jul 17, 1987 | |
| ABITREXATE | ABIC | ANDA 089355 | — | Jul 17, 1987 | |
| ABITREXATE | ABIC | ANDA 089356 | — | Jul 17, 1987 | |
| ABITREXATE | ABIC | ANDA 089161 | — | Mar 10, 1987 | |
| METHOTREXATE SODIUM | HIKMA | ANDA 089341 | AP | Sep 16, 1986 | |
| METHOTREXATE SODIUM | HIKMA | ANDA 089342 | AP | Sep 16, 1986 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | HIKMA | ANDA 089340 | AP | Sep 16, 1986 | |
| METHOTREXATE SODIUM PRESERVATIVE FREE | HIKMA | ANDA 089343 | AP | Sep 16, 1986 | |
| METHOTREXATE SODIUM | ABRAXIS PHARM | ANDA 089323 | — | Jun 13, 1986 | |
| METHOTREXATE SODIUM | ABRAXIS PHARM | ANDA 089263 | — | Jun 13, 1986 | |
| METHOTREXATE SODIUM | ABRAXIS PHARM | ANDA 089322 | — | Jun 13, 1986 | |
| METHOTREXATE SODIUM | NORBROOK | ANDA 088648 | — | May 09, 1986 | |
| FOLEX PFS | PHARMACIA AND UPJOHN | ANDA 089180 | — | Jan 03, 1986 | |
| FOLEX | PHARMACIA AND UPJOHN | ANDA 088954 | — | Oct 24, 1985 | |
| METHOTREXATE SODIUM | ABRAXIS PHARM | ANDA 088935 | — | Oct 11, 1985 | |
| METHOTREXATE SODIUM | ABRAXIS PHARM | ANDA 088936 | — | Oct 11, 1985 | |
| METHOTREXATE SODIUM | ABRAXIS PHARM | ANDA 088937 | — | Oct 11, 1985 | |
| MEXATE-AQRLD | BRISTOL MYERS | ANDA 088760 | — | Feb 14, 1985 | |
| FOLEXRLD×3 | PHARMACIA AND UPJOHN | ANDA 087695 | — | Apr 08, 1983 | |
| MEXATERLD×4 | BRISTOL | ANDA 086358 | — | Approved Prior to Jan 1, 1982 |
Listed patents (7)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10231927 | Jan 02, 2033 | in 6 yr 8 mo | U-1699 |
| 11116724 | Jan 02, 2033 | in 6 yr 8 mo | U-1349 |
| 11969503 | Jan 02, 2033 | in 6 yr 8 mo | Product |
| 12396947 | Jan 02, 2033 | in 6 yr 8 mo | Product |
| 10610485 | Jan 02, 2033 | in 6 yr 8 mo | Product |
| 9855215 | Jan 02, 2033 | in 6 yr 8 mo | Product |
| 9259427 | Jan 02, 2033 | in 6 yr 8 mo | Product |
Methotrexate sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

